Dr. Talcott is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Union Sq E
New York, NY 10003Phone+1 212-844-6450
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1984 - 1987
- University of WashingtonChief Residency, Internal Medicine, 1983 - 1984
- University of WashingtonResidency, Internal Medicine, 1981 - 1983
- University of WashingtonInternship, Internal Medicine, 1980 - 1981
- Yale School of MedicineClass of 1980
Certifications & Licensure
- NY State Medical License 2011 - 2026
- KY State Medical License 2022 - 2024
- AR State Medical License 2023 - 2023
- MN State Medical License 2021 - 2023
- WA State Medical License 1981 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
- Whos Who in Medicine and Healthcare Marquis Whos Who
Publications & Presentations
PubMed
- 616 citationsThe CAG repeat within the androgen receptor gene and its relationship to prostate cancer.Edward Giovannucci, Meir J. Stampfer, Krishna Krithivas, Myles Brown, Adam Brufsky
Proceedings of the National Academy of Sciences of the United States of America. 1997-04-01 - 70 citationsPatient‐reported outcomes after 3‐dimensional conformal, intensity‐modulated, or proton beam radiotherapy for localized prostate cancerPhillip J. Gray, Jonathan J. Paly, Beow Y. Yeap, Martin G. Sanda, Howard M. Sandler
Cancer. 2013-05-01 - 724 citationsThe Multinational Association for Supportive Care in Cancer Risk Index: A Multinational Scoring System for Identifying Low-Risk Febrile Neutropenic Cancer PatientsJean Klastersky, Marianne Paesmans, Edward B. Rubenstein, Michael Boyer, Linda S. Elting
Journal of Clinical Oncology. 2000-08-16
Press Mentions
- Advanced Treatment-Validation Technology Set to Improve Cancer Treatment ResultsJuly 20th, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: